Algeria vs Poland: Cause of death, by non-communicable diseases, ages 15-59, female
Algeria
70.8%
in 2021
Poland
71.9%
in 2021
Algeria rank
54th
Poland rank
51st
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Algeria
- Poland
How they compare
Poland currently reports 71.9% against 70.8% in Algeria, a difference of 1.1%.
Across all 6 years both countries report, Poland has been ahead every year.
Algeria ranks 54th and Poland ranks 51st of 185 countries.
Poland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.7% | 85.6% | 15.9% | Poland |
| 2010s | 74.8% | 87.4% | 12.6% | Poland |
| 2020s | 64.2% | 76.0% | 11.8% | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Algeria or Poland?
- Poland, at 71.9% against 70.8% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Algeria and Poland?
- 1.1%, with Poland ahead.
- How many years of comparable data are there for Algeria and Poland?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Poland rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Algeria ranks 54th and Poland ranks 51st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.